Aspira Womens Health Inc. buy krebskrebs
Start price
24.01.22
/
50%
€14.78
Target price
24.01.23
€24.00
Performance (%)
-57.36%
End price
25.01.23
€6.30
Summary
This prediction ended on 25.01.23 with a price of €6.30. Massive losses of -57.36% were the result for the BUY prediction by krebskrebs. krebskrebs has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Aspira Womens Health Inc. | - | - | - | - |
| iShares Core DAX® | 1,16 % | 3,68 % | 4,55 % | 49,40 % |
| iShares Nasdaq 100 | 2,59 % | 3,10 % | 36,50 % | 89,17 % |
| iShares Nikkei 225® | 7,11 % | 10,60 % | 61,22 % | 69,64 % |
| iShares S&P 500 | 1,26 % | 1,67 % | 25,23 % | 65,89 % |
Comments by krebskrebs for this prediction
In the thread Vermillion Inc. diskutieren
In the thread Trading Vermillion Inc.
Die von krebskrebs gewählte maximale Laufzeit wurde überschritten